Business Cases & Tech: Transition from POCs
to robust, enterprise-wide applications that deliver real value and ROI

03 - 05 December, 2024 | Sheraton Amsterdam Airport Hotel and Conference Center; Amsterdam, The Netherlands

Download 2024 agenda

Become a sponsor

Jonathan Crowther

Head, Predictive Analysis Pfizer

Jonathan Crowther's career trajectory from clinical intelligence to a leading role in predictive analytics epitomizes his adaptability and forward-thinking approach in the pharmaceutical industry. His foundational work in clinical intelligence has been crucial in shaping his expertise in data-driven strategies and clinical operations. Now, as a prominent figure in integrating advanced technologies into R&D, Jonathan leverages his unique blend of clinical insight and technical prowess. His leadership in predictive analytics at Pfizer demonstrates a commitment to revolutionizing pharmaceutical research and development through machine learning and AI. Join Jonathan at the Generative AI Summit, where he brings his rich experience and visionary perspective to explore the transformative impact of GenAI in healthcare.

Main Conference Day 2, Wednesday, 5 December 2024

2:15 PM Unlocking the Future: Harnessing Generative AI to Transform Pharmaceutical Innovation

• Potential for efficiency and cost reduction

• Dealing with data silos, regulatory compliance, and workforce readiness

• Transformative capabilities of Generative AI and realities of its adoption

• Best practices for effective integration to harness its full potential for healthcare

innovation

Check out the incredible speaker line-up to see who will be joining Jonathan.

Download The Latest Agenda

In Partnership With :

Connect With Us

Questions?

Tel: +49 30 52001534

E-mail: eq@iqpc.de

Imprint:
Company information according to § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Address: Rosenstrasse 2, 10178 Berlin, Germany
Tel: 49 30 52 001 534
E-mail: info@iqpc.de
Registered at: Amtsgericht Charlottenburg, HRB 76720
VAT-Number: DE210454451
Management: Torben Haagh, Richard A. Worden, Michael R. Worden